Home / Business and Economy / FutureCure Raises $11.5M for Vertigo Care Expansion
FutureCure Raises $11.5M for Vertigo Care Expansion
6 Jan
Summary
- FutureCure Health secured Rs 104 crore funding led by Carnelian Asset Management.
- The company aims to expand access to vertigo diagnosis and treatment.
- NeuroEquilibrium, a subsidiary, uses tech to bridge specialist doctor shortages.
FutureCure Health, a healthcare technology firm specializing in super-speciality care, has successfully secured Rs 104 crore ($11.5 million) in a recent funding round. The investment was spearheaded by Carnelian Asset Management LLP, with contributions from other investors, bolstering the company's mission to enhance healthcare accessibility.
These newly acquired funds are earmarked for significant expansion, particularly in making vertigo diagnosis and treatment more widely available. FutureCure operates NeuroEquilibrium, a wholly-owned subsidiary that runs specialized clinics for dizziness and vertigo. This chain focuses on identifying the root causes of vertigo, employing advanced diagnostics and cloud-based remote platforms to deliver precise care.
The company's innovative approach tackles a global shortage of neuro-otology specialists. By integrating deep-tech, FutureCure aims to scale precision medicine beyond urban centers and expand into areas like migraine and diabetes management, ultimately democratizing specialized healthcare.
